Replies to post #80 on VolitionRX Limited (VNRX)

[rodman]

Compvany still had 11 million in the bank on 3/31/15. Wait for the colonoscopy test results.

"VolitionRx now has sufficient cash to take as well into the second half of 2016, by which time we should have released substantial amounts of clinical data from several of our ongoing clinical trials and have European regulatory approval CE mark. We ended the quarter Q1 with about $11 million in the bank."

Patiencce many are still sitting on th sidelines and a run
up is emminent to IMO $8.